Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides

PLoS Pathogens

Volumn 11, Issue 9, 2015, Pages 1-24

  Schafer, Jamie L ^a   Ries, Moritz ^b   Guha, Natasha ^a   Connole, Michelle ^a   Colantonio, Arnaud D ^a   Wiertz, Emmanuel J ^c   Wilson, Nancy A ^b   Kaur, Amitinder ^a   Evans, David T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS PROTEIN; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND; MAMU-A 01 ANTIGEN; PEPTIDE; RECOMBINANT PROTEIN; VIRAL PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL SELECTION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; IMMUNE DEFICIENCY; LUCIFERASE ASSAY; MOLECULAR DOCKING; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; ALLELE; ANIMAL; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL LINE; CHEMISTRY; COCULTURE; GENETICS; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIROLOGY; VIRUS REPLICATION;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE EVASION; KILLER CELLS, NATURAL; LIGANDS; MACACA MULATTA; PEPTIDES; RECEPTORS, KIR; RECOMBINANT PROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84943545397     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005145     Document Type: Article

References (53)

1. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P, The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med. 1995;181(3):1133–44. Epub 1995/03/01. 7532677; PubMed Central PMCID: PMC2191933.
2. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med. 1995;182(2):605–9. Epub 1995/08/01. 7629517; PubMed Central PMCID: PMC2192139.
3. Schafer JL, Colantonio AD, Neidermyer WJ, Dudley DM, Connole M, O'Connor DH, et al. KIR3DL01 Recognition of Bw4 Ligands in the Rhesus Macaque: Maintenance of Bw4 Specificity since the Divergence of Apes and Old World Monkeys. J Immunol. 2014. Epub 2014/01/24. doi: 10.4049/jimmunol.1302883 24453246.
4. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D, HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998;391(6665):397–401. Epub 1998/02/05. doi: 10.1038/34929 9450757.
5. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM, Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med. 1996;2(3):338–42. Epub 1996/03/01. 8612235.
6. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 1999;10(6):661–71. Epub 1999/07/14. doi: 10.1016/S1074-7613(00)80065-5 10403641.
7. Carrington M, Martin MP, van Bergen J, KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008;16(12):620–7. Epub 2008/11/04. doi: 10.1016/j.tim.2008.09.002 18976921.
8. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31(4):429–34. Epub 2002/07/23. doi: 10.1038/ng934 12134147.
9. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39(6):733–40. Epub 2007/05/15. doi: 10.1038/ng2035 17496894.
10. Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, et al. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2006;2(8):e79. Epub 2006/08/29. doi: 10.1371/journal.ppat.0020079 16933987; PubMed Central PMCID: PMC1550271.
11. Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 2005;6(8):683–90. Epub 2005/08/27. doi: 10.1038/sj.gene.6364256 16121209.
12. Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, Oksenberg JR, Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 2007;3(4):e43. Epub 2007/04/24. doi: 10.1371/journal.ppat.0030043 17447840; PubMed Central PMCID: PMC1853116.
13. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004;305(5685):872–4. Epub 2004/08/07. doi: 10.1126/science.1097670 15297676.
14. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med. 2005;201(7):1069–75. Epub 2005/04/06. 15809352; PubMed Central PMCID: PMC2213116.
15. Chen C, Busson M, Rocha V, Appert ML, Lepage V, Dulphy N, et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant. 2006;38(6):437–44. Epub 2006/08/08. doi: 10.1038/sj.bmt.1705468 16892071.
16. Song R, Lisovsky I, Lebouche B, Routy JP, Bruneau J, Bernard NF, HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets. PLoS Pathog. 2014;10(1):e1003867. Epub 2014/01/24. doi: 10.1371/journal.ppat.1003867 24453969; PubMed Central PMCID: PMC3894215.
17. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med. 2007;204(12):3027–36. Epub 2007/11/21. 18025129; PubMed Central PMCID: PMC2118524.
18. Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, et al. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol. 2009;83(13):6798–805. Epub 2009/04/24. 19386717; PubMed Central PMCID: PMC2698561.
19. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature. 2011;476(7358):96–100. Epub 2011/08/05. doi: 10.1038/nature10237 21814282.
20. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature. 2011;479(7373):401–5. Epub 2011/10/25. doi: 10.1038/nature10517 22020283.
21. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD, Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature. 2000;405(6786):537–43. Epub 2000/06/13. doi: 10.1038/35014520 10850706.
22. Fan QR, Long EO, Wiley DC, Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol. 2001;2(5):452–60. Epub 2001/04/27. doi: 10.1038/87766 11323700.
23. Rajagopalan S, Long EO, The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med. 1997;185(8):1523–8. Epub 1997/04/21. 9126935; PubMed Central PMCID: PMC2196286.
24. Mandelboim O, Wilson SB, Vales-Gomez M, Reyburn HT, Strominger JL, Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A. 1997;94(9):4604–9. Epub 1997/04/29. 9114037; PubMed Central PMCID: PMC20770.
25. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol. 2004;34(6):1673–9. Epub 2004/05/27. doi: 10.1002/eji.200425089 15162437.
26. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, Cazaly A, et al. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A. 2010;107(22):10160–5. Epub 2010/05/05. doi: 10.1073/pnas.0913745107 20439706; PubMed Central PMCID: PMC2890497.
27. Colantonio AD, Bimber BN, Neidermyer WJ, Jr.Reeves RK, Alter G, Altfeld M, et al. KIR polymorphisms modulate peptide-specific binding to an MHC class I ligand with a Bw6 motif. PLoS Pathog. 2011;7(3):e1001316. Epub 2011/03/23. doi: 10.1371/journal.ppat.1001316 21423672.
28. Somanchi SS, Senyukov VV, Denman CJ, Lee DA, Expansion, purification, and functional assessment of human peripheral blood NK cells. J Vis Exp. 2011;e2540(48). Epub 2011/02/23. doi: 10.3791/2540 21339714.
29. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 1995;375(6530):411–5. Epub 1995/06/01. doi: 10.1038/375411a0 7760935.
30. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, et al. A viral inhibitor of peptide transporters for antigen presentation. Nature. 1995;375(6530):415–8. Epub 1995/06/01. doi: 10.1038/375415a0 7760936.
31. Loffredo JT, Sidney J, Wojewoda C, Dodds E, Reynolds MR, Napoe G, et al. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol. 2004;173(8):5064–76. Epub 2004/10/08. doi: 10.4049/jimmunol.173.8.5064 15470050.
32. O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, et al. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. J Immunol. 2014;192(6):2875–84. Epub 2014/02/25. doi: 10.4049/jimmunol.1303142 24563253; PubMed Central PMCID: PMC3948114.
33. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol. 2011;186(5):2990–7. Epub 2011/01/29. doi: 10.4049/jimmunol.1003078 21270408.
34. Willcox BE, Thomas LM, Bjorkman PJ, Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol. 2003;4(9):913–9. Epub 2003/08/05. doi: 10.1038/ni961 12897781.
35. Feng Y, Qi J, Zhang H, Wang J, Liu J, Jiang F, et al. X-ray crystallographic characterization of rhesus macaque MHC Mamu-A*02 complexed with an immunodominant SIV-Gag nonapeptide. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006;62(Pt 1):13–5. Epub 2006/03/03. doi: 10.1107/S1744309105038704 16511250; PubMed Central PMCID: PMC2150927.
36. Liu J, Dai L, Qi J, Gao F, Feng Y, Liu W, et al. Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus. J Virol. 2011;85(14):7372–83. Epub 2011/05/13. 21561910; PubMed Central PMCID: PMC3126565.
37. Peruzzi M, Wagtmann N, Long EO, A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med. 1996;184(4):1585–90. Epub 1996/10/01. 8879234; PubMed Central PMCID: PMC2192820.
38. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, et al. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol. 2011;85(12):5970–4. Epub 2011/04/08. 21471246; PubMed Central PMCID: PMC3126328.
39. Fadda L, Korner C, Kumar S, van Teijlingen NH, Piechocka-Trocha A, Carrington M, et al. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog. 2012;8(7):e1002805. Epub 2012/07/19. doi: 10.1371/journal.ppat.1002805 22807681; PubMed Central PMCID: PMC3395618.
40. van Teijlingen NH, Holzemer A, Korner C, Garcia-Beltran WF, Schafer JL, Fadda L, et al. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03: 04 and modulate primary natural killer cell function. AIDS. 2014;28(10):1399–408. Epub 2014/05/03. doi: 10.1097/QAD.0000000000000284 24785948.
41. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, et al. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol. 2007;178(1):33–7. Epub 2006/12/22. doi: 10.4049/jimmunol.178.1.33 17182537.
42. DeGottardi MQ, Specht A, Metcalf B, Kaur A, Kirchhoff F, Evans DT, Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by Nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol. 2008;82(6):3139–46. Epub 2008/01/18. 18199657; PubMed Central PMCID: PMC2258998.
43. Cassidy S, Mukherjee S, Myint TM, Mbribindi B, North H, Traherne J, et al. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. Eur J Immunol. 2014. Epub 2014/11/02. doi: 10.1002/eji.201444613 25359276.
44. Sambrook JG, Bashirova A, Palmer S, Sims S, Trowsdale J, Abi-Rached L, et al. Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res. 2005;15(1):25–35. Epub 2005/01/06. doi: 10.1101/gr.2381205 15632087; PubMed Central PMCID: PMC540275.
45. Hershberger KL, Shyam R, Miura A, Letvin NL, Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol. 2001;166(7):4380–90. Epub 2001/03/20. 11254692.
46. Blokhuis JH, van der Wiel MK, Doxiadis GG, Bontrop RE, The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics. 2010;62(5):295–306. Epub 2010/03/06. doi: 10.1007/s00251-010-0434-3 20204612; PubMed Central PMCID: PMC2858804.
47. Boyson JE, Shufflebotham C, Cadavid LF, Urvater JA, Knapp LA, Hughes AL, et al. The MHC class I genes of the rhesus monkey. Different evolutionary histories of MHC class I and II genes in primates. J Immunol. 1996;156(12):4656–65. Epub 1996/06/15. 8648109.
48. Bostik P, Kobkitjaroen J, Tang W, Villinger F, Pereira LE, Little DM, et al. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J Immunol. 2009;182(6):3638–49. Epub 2009/03/07. doi: 10.4049/jimmunol.0803580 19265142.
49. National Research Council (U.S.)Committee for the Update of the Guide for the Care and Use of Laboratory AnimalsInstitute for Laboratory Animal Research (U.S.)National Academies Press (U.S.)Guide for the care and use of laboratory animals. 8th ed. Washington, D.C.: National Academies Press. xxv, 220 p. p.
50. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R, Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A. 1988;85(1):227–31. Epub 1988/01/01. 3257565; PubMed Central PMCID: PMC279517.
51. Lahm HW, Stein S, Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr. 1985;326:357–61. Epub 1985/06/19. 3875623.
52. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12. Epub 2004/07/21. doi: 10.1002/jcc.20084 15264254.
53. O'Doherty U, Swiggard WJ, Malim MH, Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol. 2000;74(21):10074–80. Epub 2000/10/12. 11024136; PubMed Central PMCID: PMC102046.